Cardiovascular Sciences

Cardiovascular Sciences, Inc. is a medical technology company based in Orlando, Florida, focused on developing a diverse portfolio of products for the cardiovascular and surgical markets. The company's pipeline includes patented anti-adhesion technologies designed to prevent post-surgical scarring and complications, as well as pyruvate-based therapies for treating cardiac trauma, heart failure, and ischemic reperfusion injury. Additionally, the company is working on thromboresistant coatings for medical devices to prevent blood clot formation and a biocompatible human vascular tissue equivalent for artery replacement during heart surgeries. Cardiovascular Sciences also develops specialized aortic catheters for use in complex cardiac procedures. While the company is publicly traded on the OTC market, it primarily operates as an early-stage developer of proprietary medical technologies and intellectual property.